Corporate News 21-Jul-22
Biocon concludes USFDA pre-approval inspection of its site in Hyderabad
Biocon announced that USFDA concluded a pre-approval inspection for Site 3, Biocon, located at Hyderabad, Telangana on 20 July 2022. Three observations were cited at the end of the Inspection.
Previous News
Biocon Ltd spurts 4.01%, rises for fifth straight session
( Hot Pursuit - 26-Apr-24 13:00 )
Sensex spurts 714 pts; auto shares in demand
( Market Commentary - Mid-Session 09-Aug-24 10:32 )
Biocon receives reaffirmation in credit rating for bank facilities
( Corporate News - 30-Nov-23 15:49 )
Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA
( Hot Pursuit - 24-Jun-24 09:34 )
Biocon Biologics receives GMP certifications for its Indian and Malaysian manufacturing units
( Corporate News - 24-Jun-24 09:01 )
Biocon Q1 PAT soars YoY to Rs 660 cr in FY25
( Hot Pursuit - 09-Aug-24 12:19 )
Biocon to discuss results
( Corporate News - 20-Apr-23 11:22 )
Biocon Biologics completes integration of Viatris' biosimilars business in 31 European countries
( Corporate News - 30-Nov-23 16:49 )
Biocon Ltd rises for third straight session
( Hot Pursuit - 15-Feb-24 13:05 )
Biocon Ltd up for third straight session
( Hot Pursuit - 02-Feb-24 13:05 )
Biocon Ltd up for fifth session
( Hot Pursuit - 06-Feb-24 13:00 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top